Alfonso Duenas-Gonzalez

6PUBLICATIONS
8CO-AUTHORS
Predictive and prognostic markersHaematological tumoursGene and molecular therapyCancer therapy (excl. chemotherapy and radiation therapy)Molecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Mar 27, 2026
Expression of Hexokinase-2 (HK2), Glutaminase-1 (GLS1) and Fatty Acid Synthase (FASN) in Gastric Cancer and Their Prognostic Significance.

Elisa García-Martínez, Leonardo S Lino-Silva, Adriana Romo-Pérez

|Jul 23, 2025
Epigenetic reprogramming of mast and cancer cells modifies tumor-promoting cytokine networks.

Alejandro Schcolnik-Cabrera, Marisol Ramírez-Yautentzi, Rodolfo Soria-Castro

|Dec 08, 2023
Selection of clinically relevant drug concentrations for in vitro studies of candidates drugs for cancer repurposing: a proposal.

Benjamin Robles-Bañuelos, Adriana Romo-Perez, Guadalupe Dominguez-Gomez

|Mar 08, 2023
Does Therapeutic Repurposing in Cancer Meet the Expectations of Having Drugs at a Lower Price?

Aurora Gonzalez-Fierro, Adriana Romo-Pérez, Alma Chávez-Blanco

|Jun 01, 2020
Antitumor effects of ivermectin at clinically feasible concentrations support its clinical development as a repositioned cancer drug.

Mandy Juarez, Alejandro Schcolnik-Cabrera, Guadalupe Dominguez-Gomez

|Feb 20, 2020
Barriers for Pharmaceutical Innovation With Focus in Cancer Drugs, the Case of Mexico.

Alfonso Duenas-Gonzalez, Aurora Gonzalez-Fierro

Pageof 1

Frequent Collaborators

2 joint publications

Alma Chávez-Blanco

1 joint publications

Alejandro Schcolnik-Cabrera

1 joint publications

Rodolfo Soria-Castro

1 joint publications

Rocío Morales-Bárcenas